Absci (ABSI) Net Cash Flow (QoQ) (2020 - 2026)
Absci (ABSI) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.60% |
| Dec 31, 2025 | 79.61% |
| Sep 30, 2025 | -221.52% |
| Jun 30, 2025 | -249.52% |
| Mar 31, 2025 | 92.85% |
| Dec 31, 2024 | 156.38% |
| Sep 30, 2024 | 65.42% |
| Jun 30, 2024 | -17.68% |
| Mar 31, 2024 | -576.97% |
| Dec 31, 2023 | -68.35% |
| Sep 30, 2023 | -82.19% |
| Jun 30, 2023 | 202.42% |
| Mar 31, 2023 | -2.47% |
| Dec 31, 2022 | 52.02% |
| Sep 30, 2022 | -252.72% |
| Jun 30, 2022 | 3.73% |
| Mar 31, 2022 | -8.89% |
| Dec 31, 2021 | -114.84% |
| Sep 30, 2021 | 408.30% |
| Jun 30, 2021 | -151.43% |